Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nathália Cristina de Jesus Pereira"'
Autor:
Lourena Emanuele Costa, Luiz Ricardo Goulart, Nathália Cristina de Jesus Pereira, Mayara Ingrid Sousa Lima, Mariana Costa Duarte, Vivian Tamietti Martins, Paula Sousa Lage, Daniel Menezes-Souza, Tatiana Gomes Ribeiro, Maria Norma Melo, Ana Paula Fernandes, Manuel Soto, Carlos Alberto Pereira Tavares, Miguel Angel Chávez-Fumagalli, Eduardo Antonio Ferraz Coelho
Publikováno v:
PLoS ONE, Vol 9, Iss 10, p e110014 (2014)
BACKGROUND: The development of cost-effective prophylactic strategies to prevent leishmaniasis has become a high-priority. The present study has used the phage display technology to identify new immunogens, which were evaluated as vaccines in the mur
Externí odkaz:
https://doaj.org/article/06571cc1799245df98f8cdcd35f00066
Autor:
Vívian T. Martins, Miguel A. Chávez-Fumagalli, Manuel Soto, Mariana C. Duarte, Mayara I. S. Lima, Lourena E. Costa, Eduardo A.F. Coelho, Carlos Alberto Pereira Tavares, Nathália Cristina de Jesus Pereira, Luiz Ricardo Goulart, Daniela P. Lage
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
Two mimotopes of Leishmania infantum identified by phage display were evaluated as vaccine candidates in BALB/c mice against Leishmania amazonensis infection. The epitope-based immunogens, namely B10 and C01, presented as phagefused peptides; were us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e3da3cafcfb575d027e0e576eb89022
https://doi.org/10.1017/s0031182015000724
https://doi.org/10.1017/s0031182015000724
Autor:
Manuel Soto, Mariana C. Duarte, Wiliam César Bento Régis, Eduardo A.F. Coelho, Nathália Cristina de Jesus Pereira, Jamil S. Oliveira, Carlos Alberto Pereira Tavares, Vívian T. Martins, Lourena E. Costa, Miguel A. Chávez-Fumagalli, Alanna Gomes da Silva, Sandra de Aguiar Soares, Maria Norma Melo, Paula S. Lage, Mônica Santos Schneider, José R.R. de Souza
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
© 2015 Elsevier Inc. The development of effective prophylactic strategies to prevent leishmaniasis has become a high priority. No less important than the choice of an antigen, the association of an appropriate adjuvant is necessary to achieve a succ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1a86387e3c9ef6c56954c2ea7728da9
https://doi.org/10.1016/j.exppara.2015.03.027
https://doi.org/10.1016/j.exppara.2015.03.027
Autor:
Esther Garde, Manuel Soto, Mariana C. Duarte, Daniela P. Lage, Carlos Alberto Pereira Tavares, Luiz Felipe Nunes Menezes Borges, Daniel Menezes-Souza, Eliane Gonçalves Paiva Lopes, Lourena E. Costa, Vívian T. Martins, Eduardo A.F. Coelho, Miguel A. Chávez-Fumagalli, Nathália Cristina de Jesus Pereira, Danielle F. de Magalhães-Soares
Publikováno v:
Veterinary parasitology. 215
Serological diagnostic tests for canine and human leishmaniasis present problems related with their sensitivity and/or specificity. Recently, an immunoproteomic approach performed with Leishmania infantum proteins identified new parasite antigens. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b343c540a2f694a14452cab32527b2d
https://pubmed.ncbi.nlm.nih.gov/26790739
https://pubmed.ncbi.nlm.nih.gov/26790739
Autor:
Tatiana G. Ribeiro, Ana Paula Salles Moura Fernandes, Mayara I. S. Lima, Carlos Alberto Pereira Tavares, Maria Norma Melo, Daniel Menezes-Souza, Luiz Ricardo Goulart, Manuel Soto, Mariana C. Duarte, Miguel A. Chávez-Fumagalli, Lourena E. Costa, Paula S. Lage, Eduardo A.F. Coelho, Vívian T. Martins, Nathália Cristina de Jesus Pereira
Publikováno v:
PLoS ONE
Digital.CSIC. Repositorio Institucional del CSIC
instname
PLoS ONE, Vol 9, Iss 10, p e110014 (2014)
Digital.CSIC. Repositorio Institucional del CSIC
instname
PLoS ONE, Vol 9, Iss 10, p e110014 (2014)
© 2014 Costa et al. The development of cost-effective prophylactic strategies to prevent leishmaniasis has become a high-priority. The present study has used the phage display technology to identify new immunogens, which were evaluated as vaccines i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72f5b73ebb25d33db8a58a1b07ea7576
http://europepmc.org/articles/PMC4198211
http://europepmc.org/articles/PMC4198211